BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer

(NASDAQ:BFRG),(NASDAQ:BFRGW), GAITHERSBURG, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology company using artificial intelligence (“AI”) and machine learning to turn complex biomedical data into actionable insights, highlights the presentation of data derived from the use of the Company's proprietary platform bfLEAP(R) with […]

SL Green and Rockpoint Announce Joint Venture for Ownership of 100 Park Avenue

(NYSE:SLG), NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE:SLG), Manhattan's largest office landlord, and Rockpoint, a Boston-based real estate private equity firm, today announced a joint venture for the ownership of 100 Park Avenue through SL Green's sale of a 49% interest to Rockpoint at a gross asset valuation of

Habit Brings Back Gotta Habit Meal Deals

IRVINE, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — When guests ask, Habit answers. Thanks to overwhelming demand, Habit is bringing back its fan-favorite Gotta Habit Meal Deals. Three craveable meals made with fresh ingredients, a side, and a drink, all at a price that proves great food doesn't have to come with compromises. At a

ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference

(NASDAQ:PROK), WINSTON-SALEM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cell therapy company focused on chronic kidney disease (CKD), today announced that ProKidney's CEO, Bruce Culleton, M.D., will present at the 44th Annual J.P. Morgan Healthcare Conference. The ProKidney management team will also host

Bread Financial Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call for Jan. 29

(NYSE:BFH), COLUMBUS, Ohio, Jan. 06, 2026 (GLOBE NEWSWIRE) — Bread Financial(R) Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and saving solutions will host a conference call on Thursday, Jan. 29, 2026, at 8:30 a.m. ET to discuss the company's fourth quarter and full year 2025 results. Conference

Aehr Test Systems to Present at the 28th Annual Needham Growth Conference on January 13

FREMONT, CA / ACCESS Newswire / January 6, 2026 / Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in solutions, today announced that President and CEO Gayn Erickson and CFO Chris Siu will be presenting at the 28th Annual Needham Growth Conference in New York on Tuesday, January 13 at 1:30 pm

PMGC Holdings Inc. Announces Strategic Share Acquisition in Micro Modular Reactor (MMR) Focused Nuclear Energy Company, Nuclea Energy Inc.

PMGC Holdings Inc. Announces Strategic Share Acquisition in Micro Modular Reactor (MMR) Focused Nuclear Energy Company, Nuclea Energy Inc. GlobeNewswire January 06, 2026 The U.S. small and micro modular reactor (SMR/MMR) market is experiencing rapid growth, driven by energy security needs, data center demand, and federal support for advanced nuclear technologies NEWPORT BEACH, Calif., Jan.

Centerra Gold Provides Notice of Fourth Quarter 2025 Results and Conference Call

Centerra Gold Provides Notice of Fourth Quarter 2025 Results and Conference Call GlobeNewswire January 06, 2026 TORONTO, Jan. 06, 2026 (GLOBE NEWSWIRE) — Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) will release its fourth quarter 2025 operating and financial results, as well as 2026 guidance and 2025 year-end estimates for mineral

Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates via Webcast

Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates via Webcast Company to host conference call and webcast at 8:30 a.m. ET on Thursday, January 8, 2026 GlobeNewswire January 06, 2026 WATERTOWN, Mass., Jan.

Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities

Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities GlobeNewswire January 06, 2026 CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”) a healthcare innovation company developing and manufacturing the enFuse(R) On-Body Delivery System (OBDS), announced today that Sanofi is making a $30 million investment to accelerate Enable's manufacturing build-out,

Scroll to Top